IS7516A - Nýtt salt peridópríls og lyfjablöndur sem innihalda það - Google Patents

Nýtt salt peridópríls og lyfjablöndur sem innihalda það

Info

Publication number
IS7516A
IS7516A IS7516A IS7516A IS7516A IS 7516 A IS7516 A IS 7516A IS 7516 A IS7516 A IS 7516A IS 7516 A IS7516 A IS 7516A IS 7516 A IS7516 A IS 7516A
Authority
IS
Iceland
Prior art keywords
peridopril
pharmaceutical preparations
preparations containing
fresh salt
fresh
Prior art date
Application number
IS7516A
Other languages
English (en)
Other versions
IS2842B (is
Inventor
Damien Gérard
Lefoulon François
Marchand Bernard
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8871521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of IS7516A publication Critical patent/IS7516A/is
Publication of IS2842B publication Critical patent/IS2842B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
IS7516A 2002-04-18 2004-10-27 Salt perindópríls og lyfjablöndur sem innihalda það. Lyf. IS2842B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204847A FR2838648B1 (fr) 2002-04-18 2002-04-18 Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
PCT/FR2003/000507 WO2003087050A2 (fr) 2002-04-18 2003-02-17 Sel de perindopril et les compositions pharmaceutiques qui le contiennent

Publications (2)

Publication Number Publication Date
IS7516A true IS7516A (is) 2004-10-27
IS2842B IS2842B (is) 2013-08-15

Family

ID=8871521

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7516A IS2842B (is) 2002-04-18 2004-10-27 Salt perindópríls og lyfjablöndur sem innihalda það. Lyf.

Country Status (37)

Country Link
US (1) US6696481B2 (is)
EP (1) EP1354873B1 (is)
JP (1) JP3737488B2 (is)
KR (1) KR100542468B1 (is)
CN (1) CN1211365C (is)
AP (1) AP1787A (is)
AR (1) AR039428A1 (is)
AT (1) ATE271036T1 (is)
AU (2) AU2003222921A1 (is)
BR (1) BR0300709A (is)
CA (1) CA2423825C (is)
CR (1) CR7576A (is)
DE (1) DE60300011T2 (is)
DK (1) DK1354873T3 (is)
EA (1) EA005676B1 (is)
EC (1) ECSP045441A (is)
ES (1) ES2224092T3 (is)
FR (1) FR2838648B1 (is)
GE (1) GEP20074211B (is)
HR (1) HRP20041079B1 (is)
IL (1) IL164424A (is)
IS (1) IS2842B (is)
MA (1) MA27115A1 (is)
ME (1) ME00454B (is)
MX (1) MXPA03002346A (is)
NO (1) NO324323B1 (is)
NZ (1) NZ524478A (is)
OA (1) OA12806A (is)
PL (1) PL359321A1 (is)
PT (1) PT1354873E (is)
RS (1) RS51694B (is)
SI (1) SI1354873T1 (is)
TN (1) TNSN04206A1 (is)
TR (1) TR200401793T4 (is)
UA (1) UA79463C2 (is)
WO (1) WO2003087050A2 (is)
ZA (1) ZA200301395B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
LT1729739T (lt) 2004-03-29 2016-11-10 Les Laboratoires Servier Kietos farmacinės kompozicijos gamybos būdas
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
EP1987828A1 (en) * 2005-01-06 2008-11-05 IPCA Laboratories Limited salts of perindopril and their use in the therapy of hypertension
ZA200708802B (en) * 2005-03-14 2009-01-28 Servier Lab An improved process for the purification of perindopril
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
SI22542A (sl) * 2007-06-04 2008-12-31 Diagen D.O.O. Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
DK2318365T3 (en) * 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
CN101766598A (zh) * 2008-12-31 2010-07-07 东英（江苏）药业有限公司 含有培哚普利的药物组合物
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
FR2985512B1 (fr) 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
FR3040303B1 (fr) * 2015-08-27 2019-04-05 Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
IL164424A (en) 2010-12-30
ES2224092T3 (es) 2005-03-01
TNSN04206A1 (en) 2007-03-12
AU2003222921A8 (en) 2003-10-27
DE60300011T2 (de) 2005-03-17
HRP20041079B1 (hr) 2013-04-30
NO20030849L (no) 2003-10-20
CN1451656A (zh) 2003-10-29
PT1354873E (pt) 2004-10-29
UA79463C2 (en) 2007-06-25
AP2004003154A0 (en) 2004-12-31
AU2003222921A1 (en) 2003-10-27
WO2003087050A2 (fr) 2003-10-23
KR100542468B1 (ko) 2006-01-11
US20030199568A1 (en) 2003-10-23
CA2423825C (fr) 2006-02-21
AR039428A1 (es) 2005-02-16
SI1354873T1 (en) 2004-12-31
CN1211365C (zh) 2005-07-20
CA2423825A1 (fr) 2003-10-18
JP2003321493A (ja) 2003-11-11
IS2842B (is) 2013-08-15
PL359321A1 (en) 2003-10-20
HK1057367A1 (en) 2004-04-02
GEP20074211B (en) 2007-10-10
RS51694B (sr) 2011-10-31
NZ524478A (en) 2004-05-28
ECSP045441A (es) 2005-03-10
OA12806A (en) 2006-07-11
EA005676B1 (ru) 2005-04-28
AU2003200700C1 (en) 2015-04-23
US6696481B2 (en) 2004-02-24
ME00454B (me) 2011-10-10
AU2003200700A1 (en) 2003-11-06
FR2838648A1 (fr) 2003-10-24
DK1354873T3 (da) 2004-11-01
IL164424A0 (en) 2005-12-18
HRP20041079A2 (en) 2004-12-31
MXPA03002346A (es) 2005-08-26
NO324323B1 (no) 2007-09-24
EP1354873B1 (fr) 2004-07-14
JP3737488B2 (ja) 2006-01-18
FR2838648B1 (fr) 2004-05-21
DE60300011D1 (de) 2004-08-19
WO2003087050A3 (fr) 2004-03-25
RS90904A (sr) 2007-02-05
AU2003200700B2 (en) 2005-01-20
MA27115A1 (fr) 2004-12-20
NO20030849D0 (no) 2003-02-24
TR200401793T4 (tr) 2004-08-23
CR7576A (es) 2008-08-21
EP1354873A1 (fr) 2003-10-22
ZA200301395B (en) 2003-09-02
EA200300334A1 (ru) 2003-12-25
AP1787A (en) 2007-10-04
ATE271036T1 (de) 2004-07-15
BR0300709A (pt) 2004-09-08
KR20030082902A (ko) 2003-10-23

Similar Documents

Publication Publication Date Title
IS7516A (is) Nýtt salt peridópríls og lyfjablöndur sem innihalda það
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
PL377931A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
IS7948A (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
NO20033538D0 (no) Nytt suksinatsalt av O-desmetyl-venlafaxine
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
DK1206281T3 (da) Formulering indeholdende moxifloxacin og natriumchlorid
DK1635791T3 (da) Farmaceutisk komposition omfattende atorvastatin og fremstillet uden granulering
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
NO20033506L (no) Parasitticidale preparater og metoder for anvendelse
NO20053874L (no) Formulering og metoder for behandling av thrombocytemi
NO20052794D0 (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
PL373163A1 (en) Salt of (s)-pantoprazole and its hydrates
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
DK1641439T3 (da) Tabletter indeholdende enrofloxacin og smags- og/eller aromastoffer